(Total Views: 473)
Posted On: 09/15/2020 2:59:36 PM
Post# of 154036
IMO
The 25m shares go to the employees that will manage the conversion from an therapeutic investigational company to an actual pharmaceutical company, and then the execution of necessary functions for that company.
Not everything that can be outsourced should be.
The 25m shares go to the employees that will manage the conversion from an therapeutic investigational company to an actual pharmaceutical company, and then the execution of necessary functions for that company.
Not everything that can be outsourced should be.
(2)
(0)
